12:00 AM
Apr 16, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Casein kinase 1α (CSNK1A; CK1-α)



In vitro and mouse studies suggest inhibiting CSNK1A and autophagy could help treat cancers expressing oncogenic Ras. In Ras-expressing human fibroblasts and colon cancer cells, siRNA targeting CSNK1A or a small...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >